IWILFIN: payments to doctors
Payments that named IWILFIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $273K
- Providers
- 318
- Transactions
- 505
- Average per transaction
- $540
The per-transaction average — $540 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 318 providers the average total is $858, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| USWM, LLC | $199,160 | 73.0% |
| HEMA Biologics, LLC | $73,664 | 27.0% |